Why Are Safe Haven Assets Disappearing?The push for safer trading is sharply reducing the supply of safe haven assets, experts say.
Euro Bank Earnings In Focus With US on HolidayMinutes from the Fed's February meeting shouldn't offer too many surprises.
Flipping Houses: Is It Better Than the Buy and Hold Strategy?Real estate investors can choose to flip a property or hold it. Find out which strategy may best for you.
How Timing Impacts Retirement Portfolio LongevityIt's crucial to have a plan in place to ensure retirement capital lasts.
Snapchat Has Big Competition in ChinaIt would be difficult for the Snapchat app to enter the Chinese market.
Food Giants Pour Money into StartupsBig food companies are investing a ton of money into startups, will the strategy of innovation work?
Natural Gas ETFs Poised to Extend Losses (UNG)After falling 23 percent from the start of 2017, things may be getting worse for UNG.
ArQule Liver Cancer Drug Fails Phase 3 (ARQL)ArQule’s liver cancer drug ARQ 197 failed a late-stage clinical trial.
Roche Sues Amgen Over Avastin Biosimilar (AMGN)Roche filed suit to fend off competition from Amgen’s biosimilar for its bestselling drug Avastin.
Alexion Shelves Rare-Disease Drug SBC-103 (ALXN)Alexion has shelved its mucopolysaccharidosis drug SBC-103, which it acquired in 2015.